Press release
Radiopharmaceutical Theranostics Market: Exponential Growth, Key Stakeholders, and Emerging Trends
Radiopharmaceutical Theranostics Market Share
Stellar Growth in Radiopharmaceutical Theranostics Market Driven by Innovations in Nuclear Medicine and Rising Incidence of Cancer
What Is The Projected Market Size Of The Global Radiopharmaceutical Theranostics Market And Its Growth Rate?
The global radiopharmaceutical theranostics market has exhibited significant growth and is expected to continue this trend.
•2024 Market Size: $2.88 billion
•2025 Market Size: $3.27 billion (13.7% CAGR)
•2029 Market Size: $5.76 billion (15.2% CAGR)
The market growth is spurred by developments in radiopharmaceuticals as well as progress in nuclear medicine and clinical research.
What Is Driving The Growth In The Radiopharmaceutical Theranostics Market?
The growth of the radiopharmaceutical theranostics market is predominantly driven by the rising incidence of cancer. Cancer, being an abnormal growth of cells that can invade and spread to other parts of the body, finds a targeted and personalized treatment approach via radiopharmaceutical theranostics. As per estimates from the American Cancer Society, around 1.9 million new cancer cases were diagnosed in the US in 2023, with about 609,820 deaths associated with the disease. Significantly, around 88% of these incidents involved individuals from the age group of 50 years and above, thus emphasizing the utility of radiopharmaceutical theranostics in cancer treatment.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp
Who Are the Key Players Driving Radiopharmaceutical Theranostics Market Growth?
The key players propelling the growth in the market include:
•Cardinal Health Inc.
•GE HealthCare Technologies Inc.
•Bayer AG
•China Grand Pharmaceutical & Healthcare
•Lantheus Medical Imaging Inc.
•Curium Pharma
•Advanced Accelerator Applications
•Telix Pharmaceuticals Ltd.
•Bracco Imaging S.p.A
•NTP Radioisotopes SOC Ltd.
And many more.
What Are The Key Trends In The Radiopharmaceutical Theranostics Market?
The major trends shaping the market are:
•Ethical and legal considerations
•Telemedicine in theranostics
•Patient-centric care
•Radiopharmaceutical customization
•Nano-theranostics development
What Are The Segments Of The Global Radiopharmaceutical Theranostics Market?
The market segments include:
1) Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) Source: Nuclear Reactors, Cyclotrons
3) Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and other radioscopes.
4) Indication: Oncology, Cardiology, Neurology, Other Indications
5) End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users
Which Region Leads The Radiopharmaceutical Theranostics Market?
North America emerged as the largest region in the radiopharmaceutical theranostics market in 2024. The market report covers other regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report
What Is Covered In The Radiopharmaceutical Theranostics Market Global Market Report?
- Market Size Analysis: Analyze the Radiopharmaceutical Theranostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Radiopharmaceutical Theranostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Radiopharmaceutical Theranostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Radiopharmaceutical Theranostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11951&type=smp
Learn More About The Business Research Company
The Business Research Company offers over 15,000+ reports across 27 industries and covers 60+ geographies. Our Global Market Model, a premier market intelligence platform, delivers comprehensive and updated forecasts to aid strategic decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Theranostics Market: Exponential Growth, Key Stakeholders, and Emerging Trends here
News-ID: 3836851 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Radiopharmaceutical
Radiopharmaceutical Preclinical CRO Market Dynamics Shaped by Increasing Focus o …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radiopharmaceutical Preclinical CRO Market Size, Share & Trends Analysis Report By Organization Size (Small and Medium Enterprises (SMEs), Large Pharmaceutical Corporations), Radiopharmaceutical Types (PET Tracers, SPECT Tracers, Therapeutic Radiopharmaceuticals), Services (Safety Assessment, Bioanalytical Testing, Dose Formulation, Regulatory Affairs Support) Therapeutic Area (Oncology, Cardiology, Neurology), End-Users (Pharmaceutical Companies, Biotechnology Firms, Academic Research Institutions, Government Organizations)- Market…
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care.
The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,…
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322
The report provides a comprehensive analysis of company profiles listed below:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
-…
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction
According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the…
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals.
Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
According to the…
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological…
